Top Markets
#1 Black Phoenix Black Phoenix +360.62%
#2 Islamic Coin Islamic Coin +158.11%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.43%
#5 Akedo Akedo +47.69%
#6 BasedHype BasedHype +32.23%
#7 Acurast Acurast +28.01%
#8 Cryptopia Cryptopia +22.04%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Playnance Playnance +18.61%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Classement en actions #41303
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Prix de l'action
$0.0003
Dernière synchronisation: 2023-06-13
Capitalisation boursière
$28.14K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Neuropathix, Inc. (NPTX)

Catégorie

Healthcare
Bénéfices pour Neuropathix, Inc. (NPTX)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Neuropathix, Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Neuropathix, Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE